Today In Business | Celebrex Approved For Children

Published: December 16, 2006

Pfizer won federal approval to market its Celebrex painkiller as a treatment for rheumatoid arthritis in children ages 2 and older.

A government advisory committee had recommended approval in November, the Food and Drug Administration said. Celebrex is similar to Vioxx from Merck & Company, which was withdrawn in 2004 after company studies linked it to elevated risks of heart attacks and strokes.